Home LiteratureArticle Details
PMID: 2371377 Published · ppublish English Journal Article

Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha.

Radiation research ·Vol. 123 ·No. 1 ·1990-07-00 ·Pages 112-5

Wu SG, Miyamoto T

Abstract

Recombinant human interleukin-1 alpha (rHIL-1 alpha or IL-1) protected the intestinal crypt cells of mice against X-ray-induced damage. The survival of crypt cells measured in terms of their ability to form colonies of regenerating duodenal epithelium in situ was increased when IL-1 was given either before or after irradiation. The maximum degree of radioprotection was seen when the drug was given between 13 and 25 h before irradiation. The IL-1 dose producing maximum protection was about 6.3 micrograms/kg. This is the first report indicating that the cytokine IL-1 has a radioprotective effect in the intestine. The finding suggests that IL-1 may be of potential value in preventing radiation injury to the gut in the clinic.

MeSH Terms
Animals Humans Interleukin-1/therapeutic use Intestine, Small/cytology,radiation effects Male Mice Mice, Inbred C3H Radiation Injuries, Experimental/prevention & control Radiation-Protective Agents/therapeutic use Recombinant Proteins
Chemicals
Interleukin-1 Radiation-Protective Agents Recombinant Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wu S G
Hospital, National Institute of Radiological Sciences, Chiba City, Japan.
Miyamoto T
Article Info
Journal
Radiation research
Abbr.
Radiat Res
ISSN
0033-7587
Published
1990-07-00
Pages
112-5
Language
English
Region
United States
NLM ID
0401245
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]